Scholarlink

<p>Targeted delivery of photosensitizers represents a key strategy for improving the selectivity and efficacy of antimicrobial photodynamic therapy (aPDT). Herein, we describe the synthesis and biological evaluation of siderophore-conjugated photosensitizers designed to exploit bacterial iron acquisition pathways. Four distinct photosensitizers—neutral porphyrin (TPP), cationic porphyrin (TMPyP), metalloporphyrin (PdTMPyP), and chlorin (Ce6)—were covalently linked to deferoxamine B (DFO), a clinically approved hydroxamate siderophore. The resulting conjugates retained their intrinsic photophysical properties while exhibiting iron-dependent antimicrobial activity against siderophore-utilizing pathogens. TMPyP-DFO (<b>3</b>) was determined as the best compound, demonstrating potent antimicrobial photodynamic activity against <i>Staphylococcus aureus</i> and <i>Acinetobacter baumannii</i> under iron-deficient conditions (MIC<sub>50</sub> = 6.3–12.5 µM) with low mammalian cytotoxicity (LC<sub>50</sub> = 146.6 µM). Neutral porphyrin- and chlorin-siderophore conjugates (<b>1</b> and <b>2</b>, respectively) demonstrated either poor activity or lack of selectivity. These findings validate the ‘Trojan horse’ delivery strategy—achieved through the conjugation of cationic porphyrins with siderophores—as a promising strategy for enhancing bacterial selectivity in aPDT.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Siderophore–Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy

  • 期刊论文

  • 发表日期：

    2026年3月9日

查看全文
  • Jinyoung Oh,
  • Seunghyun Choi,
  • Woojin Yang,
  • Jieun Choi,
  • Jiwon Seo

摘要

Targeted delivery of photosensitizers represents a key strategy for improving the selectivity and efficacy of antimicrobial photodynamic therapy (aPDT). Herein, we describe the synthesis and biological evaluation of siderophore-conjugated photosensitizers designed to exploit bacterial iron acquisition pathways. Four distinct photosensitizers—neutral porphyrin (TPP), cationic porphyrin (TMPyP), metalloporphyrin (PdTMPyP), and chlorin (Ce6)—were covalently linked to deferoxamine B (DFO), a clinically approved hydroxamate siderophore. The resulting conjugates retained their intrinsic photophysical properties while exhibiting iron-dependent antimicrobial activity against siderophore-utilizing pathogens. TMPyP-DFO (3) was determined as the best compound, demonstrating potent antimicrobial photodynamic activity against Staphylococcus aureus and Acinetobacter baumannii under iron-deficient conditions (MIC50 = 6.3–12.5 µM) with low mammalian cytotoxicity (LC50 = 146.6 µM). Neutral porphyrin- and chlorin-siderophore conjugates (1 and 2, respectively) demonstrated either poor activity or lack of selectivity. These findings validate the ‘Trojan horse’ delivery strategy—achieved through the conjugation of cationic porphyrins with siderophores—as a promising strategy for enhancing bacterial selectivity in aPDT.